US74017N1054
US74017N1054
Precigen, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.78B EUR | 2.04B EUR | 1.38B EUR | 1.48B EUR |
Enterprise Value | 2.78B EUR | 2.12B EUR | 1.47B EUR | 1.55B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -35.5x | -- | -- | -- |
Price to Sales | 32.48x | 23.81x | 43.59x | 177.32x |
Price to Book | 64.02x | 46.83x | 68.07x | 70.74x |
EV/Revenue | 32.45x | 24.76x | 46.47x | 185.47x |
EV/EBITDA | -78.66x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -3.59% | -5.65% | -8.49% | -4.93% |